Company Filing History:
Years Active: 2021-2023
Title: Innovations of Bin Teng in Fat Metabolism Regulation
Introduction
Bin Teng is an accomplished inventor based in Shenzhen, China. He has made significant contributions to the field of fat metabolism regulation through his innovative research and patented inventions. With a total of 2 patents, Teng is recognized for his work that aims to improve health outcomes related to energy metabolism.
Latest Patents
Teng's latest patents focus on peptides that regulate fat metabolism. The first patent describes a peptide selected from a specific group, including YLGASVPSPDPLEP (SEQ ID NO: 1), YLNNGLGAPAPYPDPLEP (SEQ ID NO: 4), PDPLEP (SEQ ID NO: 14), and PSPDPLEP (SEQ ID NO: 16). This peptide is designed to reduce fat absorption and accumulation in the liver, thereby regulating fat metabolism effectively. The second patent elaborates on the use of this peptide in preparing a medicament for treating diseases associated with abnormalities in energy metabolism, particularly those related to fat metabolism. Notably, this peptide can be administered orally, offering advantages over other general peptide products, and can serve as an active ingredient in health care products aimed at regulating fat metabolism.
Career Highlights
Bin Teng is affiliated with the Shenzhen Institutes of Advanced Technology, where he conducts his research and development. His work is pivotal in advancing the understanding and treatment of metabolic disorders, particularly those involving fat regulation.
Collaborations
Teng collaborates with esteemed colleagues, including Peigen Ren and Jian Zhang, who contribute to his research endeavors and innovations in the field.
Conclusion
Bin Teng's innovative work in the regulation of fat metabolism through peptide research showcases his commitment to improving health outcomes. His contributions are significant in the realm of metabolic health and continue to influence the development of effective treatments.